Selective Targeting of Tumorigenic Cancer Cell Lines by Microtubule Inhibitors

Newaj M. Abdullah, Gus R. Rosania, Kerby Shedden · 2009

Read Selective Targeting of Tumorigenic Cancer Cell Lines by Microtubule Inhibitors by Newaj M. Abdullah, Gus R. Rosania, Kerby Shedden (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004470.txt.

Description

Drugs that freeze the cell's internal tracks may pick out the most dangerous cancer cells, argue Newaj Abdullah, Gus Rosania, and Kerby Shedden in PLOS ONE in 2009. For cancer therapy, what counts is killing the cells with the highest power to grow tumors. Those cells may be only a small share of the tumor.

The team used a standard panel of sixty human cancer cell lines, a workhorse test set for drug screening. They examined how microtubule inhibitors, drugs that jam the tracks cells use to divide and move, hit tumorigenic lines in particular. Their analysis asks whether these drugs are selective for the worst cells, not just toxic to all. Selectivity like that is what separates a smart cancer drug from a blunt one.

Catalog record

CREATORNewaj M. Abdullah, Gus R. Rosania, Kerby Shedden
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004470

Browse the full library · About the Tower of Babel